Cargando…
Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
BACKGROUND: Tetrabenazine is the only US Food and Drug Administration‐approved drug for Huntington's disease, and deutetrabenazine was recently tested against placebo. A switching‐trial from tetrabenazine to deutetrabenazine is underway, but no head‐to‐head, blinded, randomized controlled trial...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573977/ https://www.ncbi.nlm.nih.gov/pubmed/28920068 http://dx.doi.org/10.1002/mdc3.12483 |